Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3008364	fs-lipoa1	g/l (—)	2585	3264	100.00%	Distribution not available
3008364	p-lipoa1	g/l (g/l)	116	121	0.00%
3008364	s-lipoa1	g/l (g/l)	33	33	0.00%
3008364	s-ngapob	g/l (g/l)	7	10	0.00%	Distribution not available
3008364	s-ngapoa1	g/l (g/l)	7	10	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Familial hypercholesterolemia

205

3.79

25.32

1.2

1.4

1.29

1.51

g/l

—

Familial hypercholesterolemia, with ischemic heart disease

4.39

14.95

1.3

1.4

—

1.49

—

Unspecified mental disorder

1323

0.31

14.19

1.2

1.3

1.51

1.44

g/l

—

Any mental disorder

268

2207

0.61

14.09

1.2

1.3

1.44

1.48

g/l

0.25

107

Statin medication

385

1388

1.56

13.93

1.4

1.2

1.40

1.48

g/l

0.61

Psychiatric diseases

269

2194

0.61

13.60

1.2

1.3

1.44

1.48

g/l

0.26

106

Kela-code for severe mental illness

1170

0.31

12.69

1.2

1.3

1.54

1.44

g/l

—

Substance abuse, excluding more controls

1736

0.47

12.23

1.2

1.3

1.37

1.47

g/l

1.00

Schizophrenia or delusion, excluding more controls

1105

0.30

12.20

1.3

1.61

1.45

g/l

—

Insulin medication

1474

0.45

11.54

1.2

1.3

1.42

1.48

g/l

0.38

Substance abuse

1820

0.49

10.97

1.2

1.3

1.37

1.45

g/l

0.77

Mental and behavioural disorders due to psychoactive substance use

100

1851

0.51

10.59

1.2

1.3

1.34

1.46

g/l

1.08

Schizophrenia or delusion

1024

0.33

10.43

1.3

1.61

1.43

g/l

—

Schizophrenia, schizotypal and delusional disorders

1022

0.33

10.39

1.3

1.61

1.43

g/l

—

102

1769

0.51

10.36

1.2

1.3

1.36

1.45

g/l

0.70

1714

0.50

10.34

1.2

1.3

1.36

1.45

g/l

0.70

Alcohol use disorder, Swedish definition

1650

0.49

10.21

1.2

1.3

1.35

1.44

g/l

0.67

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1436

0.45

9.81

1.2

1.3

1.38

1.45

g/l

0.50

Alcohol use disorder, ICD-based

1310

0.43

9.78

1.2

1.3

1.37

1.45

g/l

—

Mood disorders, excluding more controls

233

2195

0.64

9.77

1.2

1.3

1.48

g/l

0.01

103

Insulin, combination of fast acting with intermediate-acting or long-acting

1489

0.48

9.75

1.2

1.3

1.42

1.47

g/l

0.30

Mental and behavioural disorders due to alcohol

1615

0.50

9.41

1.2

1.3

1.36

1.45

g/l

0.68

Type 2 diabetes, wide definition

151

1630

0.60

8.65

1.3

1.33

1.47

g/l

1.31

Mood disorders

252

2442

0.68

8.46

1.2

1.3

1.48

1.47

g/l

0.06

127

Mood [affective] disorders

252

2442

0.68

8.40

1.2

1.3

1.48

1.47

g/l

0.06

127

Depression

237

2424

0.67

8.29

1.2

1.3

1.47

g/l

0.02

122

Insulin, intermediate and long-acting

1385

0.52

7.58

1.2

1.3

1.42

1.47

g/l

0.29

General examination and investigation of persons without complaint and reported diagnosis

166

1376

0.64

7.22

1.2

1.3

1.50

1.46

g/l

0.17

Diabetes, insulin treatment (Kela reimbursement)

247

2162

0.70

7.06

1.3

1.45

1.48

g/l

0.18

109

Heart failure, not strict

126

1423

0.61

7.04

1.1

1.3

1.52

1.47

g/l

0.20

Personality disorders, excluding more controls

952

0.44

6.93

1.2

1.3

1.33

1.47

g/l

—

Bleeding

149

1689

0.64

6.73

1.3

1.38

1.47

g/l

0.39

108

Other menopausal disorders

130

451

1.67

6.49

1.2

1.3

1.39

1.49

g/l

—

Alcohol dependence

796

0.41

6.41

1.1

1.3

1.34

1.45

g/l

—

Disorders of lipoprotein metabolism and other lipidaemias

330

1526

1.36

6.37

1.3

1.40

1.47

g/l

0.60

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

242

2080

0.71

6.34

1.3

1.45

1.47

g/l

0.10

104

Anxiety disorders, excluding more controls

232

2154

0.71

5.98

1.2

1.3

1.40

1.48

g/l

0.59

Specific personality disorders

741

0.42

5.92

1.3

1.40

1.46

g/l

—

Pure hypercholesterolaemia

273

1327

1.38

5.89

1.3

1.39

1.49

g/l

0.85

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

228

1594

1.41

5.82

1.3

1.21

1.50

g/l

—

Anxiety (asthma-related co-morbidities)

162

1890

0.67

5.80

1.2

1.3

1.44

1.47

g/l

0.16

Disorders of adult personality and behaviour

927

0.48

5.79

1.2

1.3

1.38

1.45

g/l

—

Conductive and sensorineural hearing loss

146

1530

0.66

5.79

1.3

1.50

1.46

g/l

0.22

Personality disorders

879

0.48

5.67

1.2

1.3

1.33

1.45

g/l

—

Other and unspecified nonorganic psychotic disorders

610

0.38

5.63

1.3

1.2

1.71

1.41

g/l

—

Dental pulpitis 1, only avohilmo

306

2127

0.75

5.55

1.3

1.40

1.50

g/l

1.04

118

Other bacterial diseases

219

2105

0.72

5.47

1.2

1.3

1.40

1.48

g/l

0.78

121

Other disorders of ear

202

1896

0.71

5.45

1.3

1.47

1.48

g/l

0.08

109

General symptoms and signs

334

2194

0.76

5.40

1.2

1.3

1.44

1.49

g/l

0.32

107

Poisoning by drugs, medicaments and biological substances

725

0.44

5.38

1.2

1.3

1.56

1.44

g/l

—

All anxiety disorders

163

1909

0.69

5.38

1.2

1.3

1.44

1.49

g/l

0.25

Polyarthropathies

163

1580

0.69

5.29

1.2

1.3

1.52

1.46

g/l

0.22

Cystitis

312

1435

1.33

5.26

1.3

1.51

1.49

g/l

0.09

Sub-endpoint used in defining T1D endpoints

759

0.47

5.23

1.1

1.3

1.52

1.43

g/l

—

Diseases of pulp and periapical tissues, including avohilmo

304

2082

0.76

5.18

1.3

1.35

1.51

g/l

1.48

115

Dental pulpitis 4, only avohilmo

309

2122

0.76

5.18

1.3

1.2

1.38

1.50

g/l

1.35

117

Dental pulpitis 4

305

2084

0.76

5.11

1.2

1.3

1.37

1.51

g/l

1.45

115

Dental pulpitis 1

306

2084

0.76

5.01

1.2

1.3

1.37

1.51

g/l

1.45

115

Other chronic obstructive pulmonary disease, including avohilmo

875

0.55

5.00

1.1

1.3

1.54

1.46

g/l

0.37

Allergic conjunctivitis

229

1650

1.37

4.99

1.3

1.21

1.51

g/l

—

Type 1 diabetes

756

0.47

4.98

1.1

1.3

1.52

1.43

g/l

—

Persons encountering health services for specific procedures and health care

290

2360

0.76

4.94

1.2

1.3

1.47

g/l

0.02

118

Sensorineural hearing loss

132

1377

0.67

4.93

1.3

1.54

1.48

g/l

0.47

Bacterial Sepsis

789

0.52

4.88

1.2

1.3

1.39

1.49

g/l

—

Anxiety disorders

249

2354

0.75

4.82

1.2

1.3

1.40

1.49

g/l

0.67

111

Degenerative diseases of the nervous system

220

0.27

4.74

1.1

1.3

—

1.50

—

Insulin, fast-acting

936

0.54

4.67

1.2

1.3

1.48

1.46

g/l

—

Insulin, fast-acting or short human

936

0.54

4.67

1.2

1.3

1.48

1.45

g/l

—

Neurotic, stress-related and somatoform disorders

249

2343

0.75

4.59

1.2

1.3

1.40

1.50

g/l

0.71

109

Benzodiazepine use

257

2409

0.76

4.57

1.3

1.44

1.47

g/l

0.15

129

Condition for Implicit Sepsis (Organ dysfunction codes)

188

1881

0.72

4.54

1.2

1.3

1.45

1.47

g/l

0.10

115

Any dementia, excluding more controls

247

0.28

4.41

1.1

1.4

—

1.47

—

Type 1 diabetes, wide definition

652

0.47

4.36

1.1

1.3

1.47

1.41

g/l

—

Dementia, including avohilmo

296

0.35

4.34

1.2

1.3

—

1.48

—

Implicit Sepsis

131

1475

0.69

4.31

1.2

1.3

1.46

1.47

g/l

—

102

Other anxiety disorders

106

1407

0.67

4.20

1.1

1.2

1.43

1.49

g/l

0.25

Parodontitis or operation codes

221

2158

0.75

4.18

1.3

1.35

1.48

g/l

1.30

124

Chronic periodontitis, including avohilmo

220

2157

0.75

4.15

1.3

1.35

1.48

g/l

1.30

124

Parodontitis

221

2157

0.75

4.15

1.3

1.35

1.48

g/l

1.30

124

Parodontitis and operation codes

204

2121

0.75

4.13

1.3

1.35

1.48

g/l

1.11

123

Disorders of choroid and retina

151

1541

0.71

4.11

1.3

1.52

1.46

g/l

—

111

Coxibs

107

371

1.54

3.98

1.2

1.37

1.50

g/l

—

Non-selective monoamine reuptake inhibitors

1020

0.61

3.93

1.3

1.52

1.53

g/l

—

Other retinal disorders

1094

0.65

3.93

1.3

1.49

1.47

g/l

—

Pneumonia, organism unspecified

229

2163

0.76

3.90

1.3

1.41

1.48

g/l

0.55

125

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

257

2320

0.78

3.85

1.3

1.41

1.48

g/l

0.55

129

Dementia

268

0.36

3.84

1.2

1.3

—

1.49

—

Dental pulpitis 2, only avohilmo

203

1383

0.75

3.83

1.3

1.41

1.52

g/l

0.67

Any dementia

230

0.31

3.81

1.1

1.3

—

1.51

—

Myocardial infarction, without ST-elevation

517

1.55

3.77

1.4

1.3

1.43

1.47

g/l

0.15

Type 1 diabetes, wide definition, subgroup 1

617

0.50

3.77

1.1

1.3

1.47

1.41

g/l

—

Intracranial trauma

155

1587

0.73

3.73

1.2

1.3

1.64

1.49

g/l

—

Other degenerative diseases of the nervous system

416

0.47

3.69

1.3

—

1.50

—

Complications of surgical and medical care, not elsewhere classified

247

2264

0.78

3.59

1.3

1.45

1.47

g/l

0.22

130

Diabetes medication

297

2259

0.80

3.54

1.3

1.46

1.48

g/l

0.13

113

Other arthrosis

121

1222

0.71

3.51

1.6

1.3

1.36

1.44

g/l

0.48

Dental caries 3

240

1574

0.78

3.47

1.2

1.3

1.36

1.51

g/l

1.32

Metabolic disorders

370

1874

1.23

3.45

1.3

1.40

1.49

g/l

1.01

101

Dental pulpitis 2

203

1359

0.76

3.41

1.3

1.38

1.53

g/l

0.99

Other reaction to severe stress, and adjustment disorders

1264

0.67

3.38

1.2

1.3

1.40

1.49

g/l

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

246

2230

0.79

3.31

1.3

1.52

1.47

g/l

0.19

133

Symptoms and signs involving cognition, perception, emotional state and behaviour

248

2196

0.79

3.30

1.3

1.48

g/l

0.02

125

Erysipelas

1300

0.69

3.30

1.3

1.37

1.48

g/l

0.72

All-cause Heart Failure

718

0.63

3.29

1.1

1.4

1.59

1.46

g/l

—

Pneumonias (Asthma/COPD co-morbidities)

271

2345

0.80

3.26

1.2

1.3

1.41

1.48

g/l

0.55

129

Dental caries 3, only avohilmo

245

1589

0.79

3.25

1.3

1.37

1.50

g/l

1.18

Injuries to the head

301

2421

0.81

3.24

1.2

1.3

1.46

1.47

g/l

0.06

135

Carpal tunnel syndrome

133

1635

0.73

3.19

1.2

1.3

1.45

1.49

g/l

0.19

Heart failure, strict

734

0.65

3.12

1.1

1.4

1.59

1.46

g/l

—

Conjunctivitis

289

2036

1.24

3.11

1.3

1.32

1.48

g/l

0.80

103

Heart failure,strict

724

0.65

3.07

1.1

1.4

1.59

1.48

g/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

306

2092

0.81

3.06

1.2

1.42

1.48

g/l

0.33

110

All pneumoniae

276

2355

0.81

3.05

1.2

1.3

1.41

1.48

g/l

0.52

130

Infections of the skin and subcutaneous tissue

133

1788

0.74

3.05

1.2

1.3

1.34

1.47

g/l

—

102

Glucagon-like peptide-1 (GLP-1) analogues

1028

0.69

3.03

1.2

1.3

1.33

1.51

g/l

1.71

Spondylopathies

207

1605

0.78

3.00

1.3

1.57

1.48

g/l

0.36

Dental caries 3 and operation codes

272

1730

0.81

2.99

1.3

1.38

1.49

g/l

1.01

Non-invasive ventilation

639

0.59

2.92

1.3

—

1.48

—

COPD

684

0.63

2.90

1.1

1.3

1.49

g/l

—

Postpartum care and examination

312

0.51

2.89

1.2

—

1.52

—

Senile cataract

117

994

0.73

2.86

1.5

1.3

1.50

1.47

g/l

—

COPD, early/later onset

676

0.62

2.85

1.1

1.3

1.49

1.47

g/l

—

Disorders of lens

143

1197

0.75

2.83

1.4

1.3

1.46

1.47

g/l

0.06

Unspecific neurodegenerative disorder

211

0.39

2.82

1.2

1.4

—

1.50

—

COPD, hospital admissions

675

0.63

2.81

1.1

1.3

1.49

1.47

g/l

—

Polycystic ovarian syndrome, consortium definition

168

1315

0.77

2.80

1.3

1.2

1.52

g/l

0.01

Diabetes mellitus

310

2242

0.82

2.80

1.3

1.48

g/l

0.02

112

Diabetes mellitus in pregnancy

769

0.69

2.79

1.4

1.2

1.57

1.46

g/l

—

COPD related to multimorbidity

513

0.57

2.79

1.1

1.3

1.56

1.47

g/l

—

Selective serotonin reuptake inhibitors

309

1974

0.82

2.79

1.2

1.3

1.36

1.50

g/l

2.16

Triptan medication for migraine, min. 3 purchases

235

1487

1.25

2.75

1.2

1.43

1.49

g/l

0.32

Care involving use of rehabilitation procedures

146

1814

0.76

2.73

1.3

1.45

1.49

g/l

0.24

Other chronic obstructive pulmonary disease

657

0.63

2.71

1.1

1.3

1.49

g/l

—

Abnormalities of gait and mobility

160

1.88

2.70

1.3

1.4

1.29

1.46

g/l

—

Asthma, unspecified (mode), excluding more controls

128

1340

0.75

2.70

1.2

1.3

1.45

1.51

g/l

0.28

Persistent delusional disorders

167

0.30

2.68

1.6

1.4

—

1.45

—

Pain, not elsewhere classified

761

0.63

2.67

1.3

1.61

1.49

g/l

—

Asthma, unspecified (mode)

128

1350

0.75

2.67

1.2

1.3

1.45

1.51

g/l

0.33

Intracranial injury

113

1476

0.74

2.66

1.2

1.3

1.45

1.46

g/l

—

Persons encountering health services in other circumstances, wide

368

2270

0.84

2.66

1.2

1.3

1.41

1.48

g/l

0.59

131

Diabetes, varying definitions

310

2232

0.83

2.66

1.3

1.48

g/l

0.01

111

Use of disulfiram, acamprosate or naltrexone

265

0.38

2.64

1.0

1.3

—

1.33

—

Nerve, nerve root and plexus disorders

297

2254

0.83

2.64

1.1

1.3

1.48

1.46

g/l

0.10

112

COPD (mode)

505

0.60

2.62

1.2

1.3

1.46

1.49

g/l

—

Autoimmune diseases excluding thyroid diseases

318

2120

0.83

2.62

1.2

1.43

1.47

g/l

0.26

111

Biguanides

261

1964

0.82

2.59

1.3

1.42

1.49

g/l

0.58

101

Other maternal disorders predominantly related to pregnancy

146

1197

0.77

2.58

1.3

1.2

1.49

1.53

g/l

—

Alzheimer disease

140

0.32

2.57

1.0

1.3

—

1.52

—

Concussion

134

1518

0.76

2.52

1.2

1.3

1.63

1.49

g/l

—

Dental caries, including avohilmo

234

1475

0.81

2.51

1.3

1.39

1.51

g/l

0.91

Influenza and pneumonia

304

2395

0.83

2.51

1.2

1.3

1.41

1.48

g/l

0.51

133

Maternal care for other known or suspected fetal problems

515

0.65

2.51

1.2

1.49

1.54

g/l

—

Anti-inflammatory and antirheumatic products, non-steroids

104

375

1.40

2.50

1.3

1.2

1.39

1.51

g/l

—

Ischaemic heart disease, wide definition

264

1354

1.22

2.47

1.4

1.3

1.43

1.47

g/l

0.28

Varicose veins

123

1229

0.76

2.47

1.3

1.37

1.49

g/l

0.67

Alzheimer disease, excluding more controls

122

0.33

2.47

1.0

1.4

—

1.57

—

Dental caries 1

235

1476

0.81

2.45

1.3

1.39

1.51

g/l

0.91

Selective deficiency of immunoglobulin G [IgG] subclasses

5.09

2.41

1.5

1.4

—

Ulcer of lower limb, not elsewhere classified

206

0.39

2.40

1.5

1.4

—

1.41

—

Coronary atherosclerosis

207

1070

1.25

2.40

1.4

1.3

1.41

1.50

g/l

0.54

Dental operations

202

1291

0.80

2.40

1.3

1.49

1.48

g/l

0.02

Lower back pain or/and sciatica

289

2400

0.83

2.40

1.2

1.3

1.41

1.47

g/l

0.44

134

Fitting and adjustment of other devices

540

0.60

2.38

1.3

1.37

1.50

g/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

787

0.66

2.38

1.2

1.3

1.52

1.48

g/l

—

Disorders of conjunctiva

305

2140

1.19

2.38

1.3

1.37

1.48

g/l

0.49

116

Dental operations, only avohilmo

214

1348

0.81

2.28

1.2

1.3

1.49

1.48

g/l

0.06

Chronic sinusitis

162

1280

1.27

2.27

1.3

1.35

1.50

g/l

1.00

Low back pain

201

1905

0.81

2.26

1.2

1.3

1.44

1.48

g/l

0.28

Gingivitis and periodontal diseases

279

1725

0.83

2.26

1.3

1.45

1.47

g/l

0.11

Migraine, single triptan purchase ok & required. ICD-code if available is included

328

1878

1.18

2.26

1.3

1.39

1.48

g/l

0.63

Triptan medication for migraine, single purchase ok

328

1878

1.18

2.26

1.3

1.39

1.48

g/l

0.63

COPD/asthma related infections

321

1901

0.84

2.24

1.3

1.35

1.48

g/l

1.48

108

COPD/asthma/ILD related infections

321

1901

0.84

2.24

1.3

1.35

1.48

g/l

1.48

108

Type 2 diabetes

297

2092

0.84

2.21

1.3

1.46

1.48

g/l

0.08

106

Spondylosis

119

1329

0.77

2.20

1.4

1.3

1.58

1.49

g/l

0.42

Renal tubulo-interstitial diseases

194

1831

0.81

2.20

1.2

1.3

1.55

1.49

g/l

—

118

Depression or dysthymia

216

1475

0.82

2.18

1.2

1.3

1.39

1.48

g/l

0.57

Dental caries 2 and operation codes, only avohilmo

231

1178

1.22

2.16

1.2

1.46

g/l

0.01

Acetic acid derivatives and related substances

365

1.37

2.16

1.3

1.2

1.31

1.50

g/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

110

1439

0.76

2.15

1.2

1.3

1.46

1.48

g/l

0.08

Asthma-related infections

122

1548

0.77

2.13

1.2

1.3

1.50

1.49

g/l

—

Asthma, hospital admission 2, infections

122

1548

0.77

2.13

1.2

1.3

1.50

1.49

g/l

—

Exposure to unspecified factor

357

2376

1.17

2.13

1.2

1.3

1.51

1.46

g/l

0.33

139

Antenatal screening

115

489

1.33

2.12

1.3

1.2

1.49

1.50

g/l

—

Other antidepressants

322

1974

0.85

2.12

1.2

1.3

1.33

1.50

g/l

2.57

Diseases of arteries, arterioles and capillaries

112

1091

0.77

2.10

1.1

1.3

1.38

1.48

g/l

0.69

Other (not insulin) diabetes medications

280

2001

0.84

2.09

1.3

1.43

1.49

g/l

0.41

Ischemic heart diseases

265

1387

1.20

2.09

1.4

1.3

1.44

1.48

g/l

0.28

Disturbances of skin sensation

743

1.33

2.08

1.2

1.3

1.37

1.46

g/l

—

Mastocytosis

5.10

2.08

1.2

1.5

—

Pityriasis rosea

5.07

2.08

1.0

1.5

—

Other benign neoplasms of uterus

0.00

2.06

0.0

1.5

—

1.50

—

Other benign neoplasms of uterus

0.00

2.06

0.0

1.4

—

1.54

—

Diseases of oesophagus, stomach and duodenum

315

2243

0.85

2.06

1.3

1.49

1.47

g/l

0.14

124

Other and unspecified immunodeficiencies with predominantly antibody defects

3.54

2.06

1.6

1.5

—

Peripheral artery disease

557

0.66

2.06

1.2

1.4

1.40

1.49

g/l

—

Dental caries 1, only avohilmo

244

1497

0.83

2.05

1.3

1.38

1.50

g/l

0.95

Persons encountering health services for other counselling and medical advice, not elsewhere classified

340

2259

0.86

2.05

1.2

1.3

1.44

1.48

g/l

0.28

130

Symptoms and signs involving the skin and subcutaneous tissue

226

1867

1.21

2.05

1.3

1.41

1.50

g/l

0.67

108

Obesity due to excess calories

105

1371

0.76

2.04

1.2

1.3

1.37

1.51

g/l

—

Headache

191

1945

0.82

2.01

1.2

1.3

1.41

1.49

g/l

0.64

Fever of other and unknown origin

124

1464

0.78

1.98

1.2

1.3

1.39

1.49

g/l

—

COPD, hospital admission 2, with asthma infections

418

0.61

1.97

1.2

1.3

1.49

1.45

g/l

—

Leiomyoma of uterus

180

820

1.24

1.96

1.3

1.54

1.48

g/l

—

Injuries to the hip and thigh

893

0.73

1.96

1.2

1.3

1.36

1.47

g/l

—

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

4.60

1.95

1.8

1.4

—

Polymyositis

4.60

1.95

1.2

1.5

—

Alzheimer’s disease, wide definition, excluding more controls

110

0.37

1.94

1.0

1.3

—

1.57

—

Complications of procedures, not elsewhere classified

204

2124

0.83

1.93

1.3

1.43

1.48

g/l

0.46

125

Sulfonylureas

409

0.62

1.93

1.3

1.4

1.22

1.51

g/l

—

Congenital malformations of great arteries

3.29

1.93

1.0

1.3

—

256

1899

0.84

1.93

1.3

1.41

1.48

g/l

0.49

108

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

256

1899

0.84

1.93

1.3

1.41

1.48

g/l

0.49

108

COPD, hospital admissions 3, with asthma pneumonia sepsis

307

0.55

1.92

1.2

1.4

1.50

1.46

g/l

—

Unknown and unspecified causes of morbidity

174

0.40

1.89

1.7

1.3

—

1.50

—

Fracture of femur

304

0.54

1.89

1.2

1.4

1.39

1.54

g/l

—

Sequelae of external causes of morbidity and mortality

532

0.64

1.89

1.2

1.3

1.30

1.49

g/l

—

Perichondritis of external ear

3.21

1.88

1.4

1.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

160

1251

0.81

1.87

1.3

1.39

1.47

g/l

0.30

Type of accident

710

0.69

1.87

1.2

1.3

1.52

1.48

g/l

—

Hyperlipidaemia, other/unspecified

651

1.32

1.84

1.3

1.4

1.40

1.48

g/l

—

Other problems related to primary support group, including family circumstances

283

0.52

1.84

1.1

1.3

—

1.59

—

COPD, hospital admissions 1, only main diagnosis

451

0.64

1.84

1.2

1.3

1.54

1.46

g/l

—

Subjective visual disturbances

552

1.36

1.83

1.3

1.23

1.50

g/l

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

688

0.72

1.80

1.1

1.3

1.33

1.49

g/l

—

Dorsalgia

313

1964

0.86

1.79

1.2

1.3

1.44

1.48

g/l

0.33

Persons encountering health services in circumstances related to reproduction

269

1553

1.18

1.79

1.3

1.2

1.46

1.44

g/l

0.07

Renal failure

686

0.71

1.78

1.1

1.3

1.50

1.46

g/l

—

Rheumatoid arthritis

766

0.72

1.77

1.1

1.3

1.55

1.46

g/l

—

Hernia

269

2130

0.86

1.75

1.2

1.3

1.52

1.45

g/l

0.49

117

Drug-induced neutropenia

138

0.36

1.74

1.2

1.4

—

1.47

—

Infective dermatitis

258

0.50

1.74

1.2

1.3

—

1.49

—

Cervical disc disorders

1056

0.76

1.73

1.3

1.50

1.47

g/l

—

Propionic acid derivatives

375

1.31

1.73

1.3

1.2

1.36

1.51

g/l

—

Nausea and vomiting

582

0.67

1.72

1.2

1.3

1.59

1.50

g/l

—

Dental pulpitis 3, only avohilmo

168

0.48

1.68

1.1

—

1.57

—

Intentional self-harm by sharp object

0.00

1.68

0.0

1.2

—

Asthma, excluding more controls

259

1612

0.86

1.66

1.2

1.3

1.43

1.50

g/l

0.48

Psychotic depression

162

0.43

1.66

1.7

1.3

—

1.57

—

Autoimmune diseases

366

2130

0.88

1.66

1.3

1.2

1.41

1.47

g/l

0.44

111

Injuries to the neck

586

0.68

1.65

1.3

—

1.46

—

Memory loss

112

1.79

1.64

1.2

1.3

—

1.57

—

Dental caries 1 and operation codes

277

1649

0.86

1.64

1.3

1.40

1.49

g/l

0.86

Event of undetermined intent

148

0.40

1.63

1.2

1.3

—

1.49

—

Obesity

159

1903

0.83

1.63

1.3

1.35

1.50

g/l

—

101

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

274

2066

0.86

1.63

1.3

1.40

1.49

g/l

0.80

112

Acute gastritis

130

0.38

1.62

1.6

1.4

—

1.42

—

Asthma

262

1635

0.86

1.62

1.2

1.3

1.43

1.51

g/l

0.55

Other diseases of pancreas

132

0.38

1.62

1.4

1.3

—

1.37

—

Coronary artery bypass grafting

266

1.43

1.61

1.2

1.4

1.36

1.45

g/l

—

Other follicular disorders

189

0.47

1.61

1.1

1.3

—

1.51

—

Obesity and other hyperalimentation

160

1909

0.83

1.61

1.3

1.35

1.50

g/l

—

102

Complications of medical and surgical care

166

1893

0.83

1.60

1.3

1.42

1.50

g/l

0.79

121

Asthma-related pneumonia or sepsis

732

0.72

1.59

1.2

1.3

1.51

1.50

g/l

—

Asthma, hospital admissions 3, pneumonia

732

0.72

1.59

1.2

1.3

1.51

1.50

g/l

—

Hypertensive heart and/or renal disease

331

0.63

1.59

1.1

1.4

1.67

1.47

g/l

—

Septicaemia

782

0.74

1.58

1.1

1.3

1.30

1.49

g/l

—

Asthma-related pneumonia

731

0.72

1.58

1.2

1.3

1.51

1.50

g/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

864

0.75

1.58

1.2

1.3

1.62

1.50

g/l

—

Fracture of lower leg, including ankle

129

1578

0.81

1.57

1.1

1.3

1.56

1.48

g/l

0.72

Dyspnoea

224

2008

0.85

1.57

1.3

1.48

1.49

g/l

0.02

113

Other disorders of eyelid

101

768

1.27

1.57

1.2

1.3

1.61

1.49

g/l

—

Other septicaemia

693

0.72

1.55

1.2

1.3

1.33

1.50

g/l

—

Myalgia

613

1.31

1.54

1.3

1.35

1.43

g/l

—

N06DA Anticholinesterases

168

0.48

1.53

1.2

1.3

—

1.55

—

Use of anticholinesterases

168

0.48

1.53

1.2

1.3

—

1.55

—

Other forms of systemic lupus erythematosus

3.37

1.53

1.0

1.3

—

Other disorders of skin and subcutaneous tissue

140

1557

0.82

1.52

1.2

1.3

1.49

1.47

g/l

—

111

Other mental disorders due to brain damage and dysfunction and to physical disease

140

0.43

1.51

1.7

1.4

—

1.38

—

Dissocial personality disorder

0.00

1.51

0.0

1.4

—

Disorders of gallbladder, biliary tract and pancreas

270

2004

0.87

1.51

1.4

1.3

1.44

1.49

g/l

0.25

116

Other or unspecified ileus, impaction or obstruction

321

0.59

1.51

1.2

1.3

—

1.55

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

269

2104

0.87

1.50

1.3

1.42

1.49

g/l

0.50

111

Agranulocytosis

218

0.50

1.50

1.2

1.4

—

1.48

—

Used for control exclusion in common control thyroid runs

356

2043

0.88

1.49

1.3

1.2

1.41

1.47

g/l

0.32

108

Symptoms and signs involving the urinary system

169

1557

0.84

1.49

1.3

1.40

1.49

g/l

—

112

Diseases of the skin and subcutaneous tissue

348

1978

0.88

1.49

1.2

1.3

1.46

1.49

g/l

0.17

105

Invasive ventilation

129

0.39

1.48

2.0

1.3

—

1.42

—

Arthropathies

319

1849

0.88

1.47

1.3

1.2

1.42

1.46

g/l

0.20

Localized swelling, mass and lump of skin and subcutaneous tissue

751

1.27

1.46

1.3

1.43

1.50

g/l

—

Asthma (mode)

259

1640

0.87

1.45

1.2

1.3

1.42

1.51

g/l

0.68

Xanthelasma of eyelid

3.16

1.44

1.0

1.4

—

Conotruncal defects

3.15

1.44

1.0

1.4

—

Other protozoal intestinal diseases

2.75

1.44

1.0

1.4

—

Stroke, including SAH

107

982

0.81

1.42

1.3

1.24

1.50

g/l

—

Persons encountering health services for examination and investigation

237

1377

0.86

1.42

1.3

1.45

1.46

g/l

0.07

Asthma (diagnoses ohter than nonallergic)

229

2264

0.86

1.41

1.2

1.3

1.44

1.47

g/l

0.21

133

Sleep apnoea, including avohilmo

360

2073

1.13

1.41

1.3

1.43

1.47

g/l

0.30

125

Fentanyl

136

0.44

1.40

1.0

1.4

—

1.40

—

Fracture at wrist and hand level

1074

0.79

1.39

1.2

1.3

1.46

1.44

g/l

—

Diseases of the digestive system

960

0.78

1.38

1.1

1.3

1.49

1.48

g/l

—

Gestational diabetes (for exclusion)

102

895

0.81

1.36

1.4

1.2

1.56

1.49

g/l

—

Other and unspecified disorders of skin and subcutaneous tissue

123

0.41

1.36

1.0

1.4

—

1.41

—

Cleft palate

2.96

1.36

1.2

1.4

—

Type 2 diabetes, strict (exclude DM1)

292

1980

0.88

1.35

1.3

1.45

1.49

g/l

0.21

Osteoporosis

343

0.64

1.35

1.1

1.4

—

1.57

—

Explicit Sepsis

855

0.77

1.35

1.2

1.3

1.30

1.48

g/l

—

Type 2 diabetes, definitions combined

292

1978

0.88

1.35

1.3

1.45

1.49

g/l

0.21

Disorders of synovium and tendon

147

1577

0.84

1.34

1.3

1.47

1.49

g/l

—

Type 2 diabetes, definitions combined, including avohilmo

297

1991

0.88

1.32

1.3

1.48

1.49

g/l

0.00

Coxarthrosis

116

959

0.82

1.32

1.3

1.66

1.47

g/l

—

343

2035

0.89

1.32

1.3

1.44

1.47

g/l

0.24

112

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

139

1158

1.20

1.32

1.2

1.3

1.58

1.44

g/l

0.64

Focal brain injury

146

0.48

1.31

1.0

1.4

—

1.39

—

Rheumatoid arthritis, including avohilmo

854

0.77

1.31

1.2

1.3

1.60

1.51

g/l

—

Soft tissue disorders

345

2012

0.89

1.31

1.2

1.3

1.51

1.46

g/l

0.36

Other diseases of pleura

706

0.76

1.29

1.3

1.43

1.47

g/l

—

Leiomyoma of uterus

208

1017

1.16

1.29

1.3

1.62

1.50

g/l

0.63

Injury, poisoning and certain other consequences of external causes

194

1134

0.86

1.29

1.3

1.56

1.45

g/l

0.68

Other and unspecified drugs and medicaments

172

0.52

1.29

1.6

1.3

—

1.42

—

Fasciculation

2.80

1.29

1.2

1.3

—

Asthma (only as main-diagnosis), excluding more controls

236

1612

0.87

1.28

1.2

1.3

1.44

1.50

g/l

0.37

Unstable angina pectoris

485

1.28

1.4

1.3

1.44

1.47

g/l

—

Hypertension, essential

266

1726

0.88

1.27

1.2

1.3

1.43

g/l

0.01

Shoulder lesions

231

1622

0.87

1.26

1.2

1.3

1.52

1.47

g/l

0.40

Other arrhythmias

170

1523

0.85

1.26

1.3

1.50

1.47

g/l

—

Lumbar disc prolapse

188

1734

0.86

1.25

1.3

1.34

1.49

g/l

0.89

Nutritional anaemias

923

0.79

1.25

1.3

1.47

1.48

g/l

—

Early onset COPD

529

0.72

1.25

1.1

1.3

1.52

1.44

g/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

223

0.58

1.25

1.4

—

1.43

—

Recurrent or chronic depression

143

1226

0.84

1.25

1.2

1.3

1.47

1.48

g/l

0.05

Asthma (only as main-diagnosis)

237

1635

0.87

1.25

1.2

1.3

1.44

1.51

g/l

0.43

Malignant neoplasm of kidney, except renal pelvis

116

0.43

1.25

1.2

1.3

—

1.34

—

Early onset COPD, excluding more controls

528

0.72

1.24

1.1

1.3

1.52

1.49

g/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

2.41

1.24

1.0

1.4

—

Combinations of oral blood glucose lowering drugs

643

0.75

1.24

1.2

1.3

1.40

1.50

g/l

—

Deposits [accretions] on teeth

155

0.50

1.24

1.1

1.4

—

1.47

—

Certain infectious and parasitic diseases

342

1915

0.89

1.22

1.3

1.44

1.50

g/l

0.41

Benign neoplasm of thyroid gland

1.97

1.22

1.7

1.5

—

1.41

—

Open wound of wrist and hand

120

1425

0.83

1.22

1.2

1.3

1.37

1.43

g/l

—

Other disorders of thyroid

2.65

1.22

2.0

1.4

—

Valvular operations

221

1.45

1.20

1.2

1.3

1.55

1.53

g/l

—

Tramadol

244

1783

0.88

1.20

1.3

1.43

1.46

g/l

0.20

108

Other nutritional deficiencies

173

1962

0.86

1.19

1.2

1.3

1.38

1.50

g/l

0.66

106

Rotator cuff syndrome

169

1461

0.86

1.18

1.2

1.3

1.54

1.46

g/l

0.57

Other and unspecified mood [affective] disorders

199

0.55

1.17

1.2

1.3

—

1.49

—

101

1214

0.82

1.16

1.2

1.3

1.56

1.49

g/l

—

Iron deficiency anaemia

818

0.79

1.15

1.3

1.47

1.48

g/l

—

Cough

1016

0.81

1.15

1.3

1.44

1.51

g/l

—

Disorder of thyroid, unspecified

2.52

1.15

2.0

1.5

—

Sciatica+with lumbago

137

1532

0.85

1.15

1.2

1.3

1.32

1.50

g/l

—

Fall on same level

377

2330

0.90

1.15

1.2

1.3

1.43

1.47

g/l

0.28

131

Coxarthrosis [arthrosis of hip](FG)

120

1036

0.84

1.14

1.3

1.62

1.46

g/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

250

1.31

1.13

1.2

1.28

1.47

g/l

—

Abnormal serum enzyme levels

529

1.27

1.13

1.4

1.3

1.35

1.46

g/l

—

Unspecified fall

1156

0.82

1.13

1.3

1.48

1.47

g/l

—

Family history of certain disabilities and chronic diseases leading to disablement

112

0.44

1.13

1.0

1.3

—

1.49

—

Carcinoma in situ of skin

1.75

1.12

1.3

1.4

—

1.44

—

Helminthiases

2.35

1.12

1.3

—

Diseases of the musculoskeletal system and connective tissue

212

1214

0.88

1.09

1.3

1.49

1.47

g/l

0.08

Crowding of teeth, including avohilmo

137

0.54

1.09

1.3

1.2

—

1.41

—

Need for other prophylactic measures

120

1.59

1.08

1.4

—

1.41

—

Infections of genitourinary tract in pregnancy

231

0.60

1.08

1.1

1.2

—

1.55

—

Osteopathies and chondropathies

115

1294

0.84

1.07

1.1

1.3

1.44

1.47

g/l

—

Sulfasalazine

816

0.80

1.06

1.2

1.3

1.53

1.48

g/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

180

0.55

1.06

1.1

1.3

—

1.48

—

Neurological diseases

314

1758

0.90

1.06

1.2

1.3

1.42

1.49

g/l

0.45

Benign neoplasm of breast

253

1.39

1.06

1.4

1.3

—

1.58

—

Diseases of the ear and mastoid process

403

2239

0.91

1.06

1.3

1.43

1.48

g/l

0.42

111

Other diseases of upper respiratory tract

402

1906

1.10

1.06

1.3

1.41

1.49

g/l

0.61

104

Delivery, wide proxy

425

0.79

1.06

1.3

1.2

1.55

1.47

g/l

—

Stroke, excluding SAH

877

0.83

1.05

1.3

1.24

1.50

g/l

—

Dysplasia of cervi uteri

571

0.78

1.05

1.1

1.2

1.64

1.54

g/l

—

Other acute lower respiratory infections

116

1308

0.85

1.04

1.3

1.45

1.47

g/l

0.10

Galactorrhea

2.29

1.03

1.2

1.3

—

Mental and behavioural disorders of puerperium, not classified elsewhere

2.29

1.03

1.0

1.3

—

Dermatopolymyositis

2.28

1.03

1.2

1.5

—

Eosinophilia

2.28

1.03

1.2

1.4

—

Special screening examination for other diseases and disorders

203

0.59

1.03

1.6

1.3

—

1.57

—

Family history of malignant neoplasm

289

1.35

1.03

1.2

1.3

—

1.49

—

Atherosclerosis, excluding cerebral and coronary sclerosis

462

0.76

1.02

1.2

1.4

1.34

1.47

g/l

—

Benign neoplasm of breast

255

1.38

1.02

1.4

1.3

—

1.52

—

Cholelithiasis, broad definition with cholecystitis

224

1731

0.89

1.02

1.4

1.3

1.35

1.49

g/l

1.18

105

Excessive attrition of teeth

128

588

1.18

1.02

1.2

1.68

1.45

g/l

—

Factors influencing health status and contact with health services

122

723

0.85

1.01

1.4

1.3

1.38

1.50

g/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

242

1377

0.89

1.01

1.3

1.49

1.46

g/l

0.09

Migraine without aura

620

0.77

1.01

1.1

1.3

1.51

1.55

g/l

—

Other condition

345

0.69

1.00

1.0

1.3

1.45

1.46

g/l

—

Viral infections of the central nervous system

176

0.57

1.00

1.3

—

1.49

—

Alzheimer’s disease, wide definition

113

0.52

0.99

1.0

1.3

—

1.58

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

188

0.58

0.99

1.5

1.3

—

1.50

—

Benign neoplasm of thyroid gland

1.81

0.98

1.7

1.4

—

1.41

—

Abnormal spermatozoa

175

0.57

0.98

1.0

1.4

—

1.37

—

Chronic diseases of tonsils and adenoids

319

1827

1.11

0.98

1.3

1.29

1.49

g/l

1.47

Other disorders of urethra and urinary system

157

1352

0.87

0.98

1.2

1.3

1.53

1.48

g/l

—

Lesion of ulnar nerve

366

0.71

0.97

1.3

1.38

1.51

g/l

—

Cardiomyopathy, other and unspecified

132

1.52

0.97

1.1

1.4

—

1.31

—

Paraplegia, diplegia of upper limbs

0.00

0.96

0.0

1.3

—

267

1.35

0.96

1.1

1.2

—

1.49

—

Viral warts

235

0.64

0.96

1.1

1.3

—

1.54

—

Finngen Rheumatological endpoints

334

2094

0.91

0.95

1.3

1.53

1.46

g/l

0.55

117

Persons encountering health services for specific procedures, not carried out

186

0.59

0.95

1.3

—

1.47

—

Vestibular neuronitis

186

0.59

0.95

1.5

1.3

—

1.39

—

Obesity related asthma

902

0.82

0.95

1.3

1.55

1.47

g/l

—

Speech therapy

586

1.23

0.95

1.2

1.3

1.42

1.51

g/l

0.51

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.95

0.0

1.3

—

1.61

—

Other disorders of the musculoskeletal system and connective tissue

306

0.69

0.95

1.1

1.3

—

1.51

—

Ptosis of eyelid

174

1.44

0.95

1.2

1.3

—

1.48

—

Crossbite

109

0.51

0.94

1.7

1.3

—

1.40

—

Female infertility, associated with anovulation

246

0.65

0.94

1.3

1.2

—

1.58

—

Pain in joint

191

1431

0.88

0.94

1.3

1.46

1.48

g/l

0.06

Azathioprine

421

0.74

0.94

1.2

1.3

—

1.46

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

2.23

0.93

1.0

1.4

—

Oedema, not elsewhere classified

709

0.80

0.93

1.2

1.3

1.35

1.50

g/l

—

Excluding asthma or asthma-COPD overlap

298

1650

0.90

0.93

1.3

1.40

1.50

g/l

0.68

Congenital malformations of eye, ear, face and neck

142

0.56

0.93

1.0

1.3

—

1.42

—

Chronic rhinitis, nasopharyngitis and pharyngitis

104

880

1.18

0.93

1.2

1.3

1.46

1.55

g/l

—

Infections with a predominantly sexual mode of transmission

112

953

1.18

0.93

1.3

1.2

1.49

1.46

g/l

—

Fibroblastic disorders

522

0.77

0.92

1.3

1.41

1.43

g/l

—

Keratoconus

1.74

0.92

1.0

1.3

—

External causes of morbidity and mortality

245

1370

0.90

0.92

1.3

1.52

1.48

g/l

0.18

Iliotibial band syndrome

2.16

0.92

1.3

1.4

—

Radial styloid tenosynovitis [de Quervain]

171

0.58

0.91

1.4

1.3

—

1.53

—

Basal cell carcinoma, including avohilmo

111

743

1.18

0.91

1.3

1.60

1.47

g/l

—

Dizziness and giddiness

183

1679

0.88

0.91

1.3

1.46

1.48

g/l

0.08

107

Hernia of abdominal wall

1136

0.84

0.91

1.3

1.48

g/l

—

Sleep apnoea

328

2027

1.10

0.90

1.3

1.43

1.46

g/l

0.20

121

Melanocytic naevi, other sites/unspecified

195

0.61

0.90

1.4

1.3

—

1.53

—

Other complications of surgical and medical care, not elsewhere classified

231

0.65

0.90

1.1

1.3

—

1.50

—

Alzheimer’s disease (Late onset)

0.48

0.90

1.0

1.3

—

1.57

—

Appendicitis, broad definition

279

2311

1.10

0.90

1.3

1.31

1.49

g/l

1.52

122

Overexertion and strenuous or repetitive movements

262

1.34

0.89

1.3

—

1.53

—

Depression medications

137

796

0.87

0.89

1.2

1.39

1.46

g/l

0.41

Coeliac disease

278

0.68

0.89

1.1

1.3

1.50

1.51

g/l

—

Bronchiectasis

103

0.48

0.89

1.8

1.4

—

1.52

—

Use of donepezil

100

0.48

0.89

1.4

1.3

—

1.60

—

Visual disturbances and blindness

134

1163

1.15

0.88

1.2

1.3

1.35

1.50

g/l

—

Any reimbursement code in KELA

254

1413

0.90

0.88

1.2

1.44

1.50

g/l

0.26

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

154

0.58

0.88

1.3

1.4

—

1.46

—

Other and unspecified iron deficiency

640

0.80

0.88

1.4

1.3

1.47

1.51

g/l

—

Cerebrovascular diseases (FINNGEN)

104

873

0.85

0.87

1.3

1.26

1.46

g/l

—

Cholelithiasis

216

1691

0.90

0.87

1.4

1.3

1.34

1.49

g/l

1.21

105

Disease of hard tissues of teeth, NOS

2.01

0.87

1.3

1.5

—

COPD differential diagnosis

298

1642

0.91

0.87

1.3

1.40

1.51

g/l

0.74

Bacterial infection, other or unspecified

1020

0.85

0.87

1.1

1.3

1.49

1.48

g/l

—

Asthma/COPD (KELA code 203)

298

2304

0.91

0.86

1.2

1.3

1.42

1.47

g/l

0.34

121

Methotrexate

357

0.73

0.86

1.2

1.3

1.42

1.52

g/l

—

Angina pectoris

148

873

1.15

0.85

1.4

1.3

1.37

1.48

g/l

—

Other/unspecified seropositive rheumatoid arthritis

560

0.78

0.85

1.1

1.3

1.63

1.52

g/l

—

ILD differential diagnosis

298

1640

0.91

0.85

1.3

1.40

1.51

g/l

0.74

Inguinal hernia

171

1303

0.88

0.85

1.2

1.3

1.45

1.43

g/l

0.10

Pain (limb, back, neck, head abdominally)

264

1462

0.90

0.85

1.3

1.51

1.47

g/l

0.24

Benign neoplasm: Colon

100

898

0.85

0.84

1.3

1.56

1.48

g/l

0.54

Benign neoplasm: Choroid

1.59

0.84

1.3

1.4

—

1.38

—

Dislocation, sprain and strain of joints and ligaments at neck level

412

0.75

0.84

1.3

—

1.51

—

Benign neoplasm of eye and adnexa

179

1.40

0.84

1.2

1.3

—

1.49

—

Diseases of appendix

279

2314

1.10

0.83

1.3

1.31

1.49

g/l

1.52

122

Other diseases of hard tissues of teeth

204

1697

0.90

0.83

1.3

1.67

1.46

g/l

1.49

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

137

0.58

0.83

1.5

1.3

—

1.53

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

250

0.68

0.83

1.1

1.3

—

1.45

—

Hypertrophic scar

137

0.58

0.83

1.0

1.3

—

1.52

—

Vulvovaginal ulceration/inflammation in other diseases

138

0.58

0.83

1.1

1.2

—

1.57

—

Hyperfunction of pituitary gland

112

0.53

0.83

2.0

1.3

—

1.45

—

Unspecified urinary incontinence

137

0.58

0.83

1.6

1.4

—

1.53

—

Vitamin B12 deficiency anaemia

138

0.58

0.83

1.1

1.4

—

1.44

—

Irregular menses

134

1243

0.87

0.82

1.3

1.2

1.45

1.53

g/l

—

Arthrosis

245

1490

0.90

0.82

1.3

1.53

1.45

g/l

0.46

Major coronary heart disease event

186

1104

1.12

0.82

1.3

1.48

g/l

0.03

Misadventures to patients during surgical and medical care

296

0.71

0.82

1.5

1.3

—

1.51

—

Zoster [herpes zoster]

296

0.71

0.82

1.2

1.3

—

1.51

—

Malignant neoplasm of testis

1.88

0.82

1.7

1.4

—

Bacterial pneumoniae

851

0.84

0.81

1.2

1.3

1.44

1.47

g/l

—

Basal cell carcinoma

105

717

1.17

0.81

1.3

1.60

1.47

g/l

—

Other intervertebral disc disorders

272

1829

0.91

0.81

1.3

1.36

1.49

g/l

1.06

Covid-19 confirmed case

626

1.20

0.81

1.3

1.44

1.54

g/l

—

Seropositive rheumatoid arthritis, wide

566

0.79

0.81

1.1

1.3

1.63

1.52

g/l

—

Other pulmonary diagnosis

301

1650

0.91

0.80

1.3

1.40

1.50

g/l

0.68

Neurological diseases, wide definition

127

733

0.87

0.80

1.2

1.47

1.45

g/l

—

Other cataract

719

0.84

0.80

1.4

1.3

1.35

1.45

g/l

—

Subarachnoid haemorrhage

176

0.62

0.79

1.3

1.4

—

1.51

—

Nystagmus and other irregular eye movements

0.00

0.79

0.0

1.3

—

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.3

—

Single spontaneous delivery

530

0.84

0.79

1.3

1.54

1.45

g/l

—

Seropositive rheumatoid arthritis

563

0.80

0.79

1.1

1.3

1.63

1.48

g/l

—

Cleft lip, lip and palate or palate

1.83

0.79

1.2

1.3

—

Nasal polyp

473

1.23

0.79

1.4

1.3

1.57

1.49

g/l

—

Charcot foot

0.00

0.79

0.0

1.5

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

553

0.79

1.1

1.3

1.63

1.51

g/l

—

Maltreatment syndromes

147

0.61

0.79

1.0

1.3

—

1.35

—

Ischaemic Stroke, excluding all haemorrhages

790

0.85

0.78

1.3

1.25

1.49

g/l

—

Portal vein thrombosis

0.00

0.78

0.0

1.3

—

Viral pneumonia (known virus, not influenza)

0.00

0.78

0.0

1.4

—

Second line medication for Crohn's disease

145

1640

0.88

0.78

1.1

1.3

1.54

1.46

g/l

—

102

ILD medications: azathioprine

407

0.76

0.78

1.2

1.3

—

1.47

—

Disorders of muscles

258

0.70

0.78

1.2

1.3

—

1.49

—

Hordeolum and other deep inflammation of eyelid

122

0.57

0.78

1.1

1.3

—

1.44

—

Malignant neoplasm of urinary organs

122

0.57

0.77

1.3

—

1.37

—

Disorders in reading

0.00

0.77

0.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

878

0.84

0.77

1.3

1.34

1.49

g/l

—

MS-disease / Multiple Sclerosis

210

0.67

0.77

1.4

1.3

—

1.59

—

Communicating hydrocephalus

0.00

0.76

0.0

1.5

—

Phlebitis and thrombophlebitis (not including DVT)

505

0.79

0.75

1.3

1.26

1.56

g/l

—

Enterocolitis due to Clostridium difficile

161

0.62

0.75

1.5

1.3

—

1.50

—

Orchitis and epididymitis

185

0.65

0.75

1.5

1.3

1.29

1.40

g/l

—

Falls/tendency to fall

389

2100

0.93

0.75

1.3

1.48

1.47

g/l

0.06

115

Mental and behavioural disorders associated with the puerperium

2.10

0.74

1.0

1.3

—

Malignant neoplasm of tongue

2.09

0.74

1.2

1.4

—

Abnormal findings on diagnostic imaging of lung

884

0.85

0.74

1.4

1.3

1.41

1.48

g/l

—

Malignant neoplasm of bronchus and lung

184

0.66

0.74

1.4

—

1.41

—

Gastro-oesophageal reflux disease

182

1792

0.90

0.74

1.3

1.40

1.47

g/l

0.54

106

Other symptoms and signs involving cognitive functions and awareness

861

0.85

0.73

1.2

1.3

1.41

1.49

g/l

—

Fracture of rib(s), sternum and thoracic spine

635

0.82

0.73

1.3

1.53

1.49

g/l

—

Corns and callosities

134

0.60

0.73

1.0

1.4

—

1.38

—

Use of teriflunomide

2.01

0.73

1.4

—

Pyogenic granuloma

2.01

0.73

1.6

1.5

—

Outcome of delivery

385

1.19

0.72

1.5

1.2

—

1.54

—

Hard cardiovascular diseases

246

1439

1.10

0.72

1.3

1.39

1.48

g/l

0.87

Deforming dorsopathies

742

0.83

0.72

1.3

1.37

1.50

g/l

—

Gonarthrosis,primary

234

1615

0.91

0.71

1.3

1.52

1.46

g/l

0.42

Other specific joint derangements/joint disorders

247

1812

0.91

0.71

1.3

1.2

1.49

1.46

g/l

0.18

Injuries to the abdomen, lower back, lumbar spine and pelvis

864

0.85

0.70

1.3

—

1.50

—

L04AX Other immunosuppressants

141

1583

0.89

0.70

1.1

1.3

1.54

1.46

g/l

—

Visual disturbances

125

1103

1.13

0.70

1.2

1.3

1.35

1.48

g/l

—

Encephalitis

1.56

0.70

1.2

1.3

—

Benign neoplasm of eye and adnexa

186

1.35

0.70

1.2

1.3

—

1.53

—

Other ulcerative colitis

143

0.63

0.69

1.6

1.3

—

1.35

—

Benign neoplasm: Choroid

1.51

0.69

1.3

1.4

—

1.43

—

Other obstructed labour

228

0.70

0.69

1.3

—

1.55

—

Carbimazole or st.post thyroidectomy, condition for graves disease

520

0.81

0.69

1.3

—

1.50

—

Parapsoriasis

1.86

0.68

1.0

1.4

—

Open wound of shoulder and upper arm

1.86

0.68

1.0

1.6

—

Thyroiditis, ILD-related definition

285

0.74

0.68

1.4

1.3

—

1.53

—

Protozoal diseases

1.67

0.68

1.1

1.4

—

Major coronary heart disease event excluding revascularizations

161

995

1.12

0.68

1.4

1.3

1.50

1.48

g/l

0.08

Abnormal findings on antenatal screening of mother

227

0.70

0.68

1.3

1.2

—

1.45

—

Intestinal malabsorption

0.53

0.66

1.2

1.4

—

1.38

—

Mouth breathing

134

1192

1.12

0.66

1.4

1.3

1.51

1.45

g/l

0.38

Melanocytic naevi, other sites/unspecified

179

0.67

0.66

1.4

1.3

—

1.51

—

Other joint disorders

322

1849

0.93

0.65

1.3

1.2

1.49

1.46

g/l

0.20

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

180

1596

1.10

0.65

1.2

1.3

1.41

1.48

g/l

0.55

Other and unspecified disorders of vitreous body

833

1.15

0.65

1.4

1.3

1.51

1.46

g/l

—

Pre-eclampsia or poor fetal growth

913

0.86

0.64

1.3

1.2

1.51

1.52

g/l

—

Acute tubulo-interstitial nephritis

125

1246

0.89

0.64

1.2

1.3

1.39

1.49

g/l

—

Venous thromboembolism

103

1137

0.88

0.64

1.3

1.35

1.47

g/l

—

Panic disorder

449

0.80

0.64

1.1

1.2

1.52

1.55

g/l

—

Transient ischemic attack

109

795

1.14

0.64

1.3

1.27

1.50

g/l

—

Lichen simplex chronicus and prurigo

129

0.62

0.63

1.0

1.4

—

1.39

—

Impacted cerumen

129

0.62

0.63

1.4

1.3

—

1.40

—

Malignant neoplasm of prostate

409

0.83

0.63

1.4

1.3

1.34

1.43

g/l

—

Parasetamol

314

1727

0.93

0.63

1.3

1.2

1.41

1.50

g/l

0.65

Exclusions for E4_PCOS_CONSORTIUM

244

1405

1.09

0.63

1.3

1.47

1.49

g/l

0.10

Other spirochaetal diseases

570

1.18

0.63

1.3

1.51

1.52

g/l

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

177

0.68

0.63

1.3

1.4

—

1.46

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

171

949

0.90

0.63

1.3

1.53

1.56

g/l

—

Dorsopathies

361

1974

0.93

0.63

1.3

1.47

1.48

g/l

0.09

Bacterial pneumonia, not elsewhere classified

789

0.86

0.62

1.2

1.3

1.44

1.48

g/l

—

Unspecified misadventure during surgical and medical care

101

0.59

0.62

1.3

1.4

—

1.42

—

Lyme disease

562

1.18

0.62

1.3

1.51

1.52

g/l

—

Acute appendicitis, no complications

214

1957

1.09

0.62

1.2

1.3

1.38

1.49

g/l

0.74

Codeine or tramadol medication

426

2215

1.07

0.61

1.3

1.2

1.53

1.46

g/l

0.62

128

Other functional intestinal disorders

948

0.87

0.61

1.4

1.3

1.53

1.48

g/l

—

Open wound of head

130

1428

0.90

0.60

1.2

1.3

1.44

1.46

g/l

0.10

Gonarthrosis [arthrosis of knee](FG)

238

1521

0.92

0.60

1.3

1.51

1.46

g/l

0.39

Hallux rigidus

280

1.25

0.60

1.2

1.3

1.53

1.48

g/l

—

Inflammatory disease of cervix uteri

138

0.65

0.60

1.0

1.3

—

1.49

—

Horner syndrome

0.00

0.60

0.0

1.4

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

0.00

0.60

0.0

1.3

—

Episcleritis

139

1.37

0.60

1.3

—

1.47

—

Palindromic rheumatism

0.00

0.60

0.0

1.3

—

Other viral diseases

832

1.14

0.60

1.3

1.47

g/l

—

Deviated nasal septum

112

994

1.13

0.60

1.3

1.42

1.47

g/l

—

Benign neoplasm of colon, rectum, anus and anal canal

131

1044

0.90

0.60

1.3

1.55

1.47

g/l

0.61

Malignant neoplasm

289

1845

0.93

0.59

1.3

1.54

1.46

g/l

0.52

111

Intracranial and intraspinal abscess and granuloma

0.00

0.59

0.0

1.3

—

Other diseases of appendix

0.00

0.59

0.0

1.4

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

0.00

0.59

0.0

1.5

—

Other encephalitis

1.54

0.59

1.3

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.00

0.59

0.0

1.4

—

Other lack of coordination

0.00

0.59

0.0

1.4

—

Myocardial infarction

119

760

1.12

0.59

1.4

1.3

1.51

1.49

g/l

0.08

Other diseases of intestines

402

2194

1.07

0.59

1.3

1.2

1.51

1.46

g/l

0.30

121

Migraine

143

1348

0.90

0.59

1.2

1.3

1.39

1.53

g/l

—

Sleep disorders (combined)

353

2165

1.07

0.58

1.3

1.43

1.47

g/l

0.31

125

Noninfective enteritis and colitis

140

1260

1.11

0.58

1.2

1.3

1.33

1.47

g/l

—

Other skin changes

288

0.76

0.58

1.3

1.4

1.45

1.46

g/l

—

Ulcerative colitis

696

1.15

0.58

1.1

1.3

1.31

1.46

g/l

—

Pain in limb

238

1861

0.92

0.57

1.2

1.3

1.45

1.47

g/l

0.11

Allergic rhinitis

104

914

1.13

0.57

1.1

1.3

1.41

1.43

g/l

—

Asthma, hospital admissions , main diagnosis only

238

2301

0.93

0.57

1.2

1.3

1.44

1.47

g/l

0.19

129

ILD medications: immunosuppressive drugs

182

1905

0.92

0.56

1.2

1.3

1.45

1.49

g/l

0.21

101

Gout, idiopatic and unspecified

364

0.80

0.56

1.3

1.4

—

1.48

—

Other diseases of urinary system

335

1763

1.07

0.56

1.3

1.53

1.49

g/l

0.22

107

Gluteal tendinitis

0.57

0.56

1.2

1.4

—

1.51

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

172

0.70

0.56

1.2

1.3

—

1.45

—

Diseases of oral cavity, salivary glands and jaws

315

1729

0.93

0.55

1.3

1.52

1.47

g/l

0.33

Delivery

530

0.88

0.55

1.3

1.54

1.45

g/l

—

Injuries to the wrist and hand

309

2393

0.94

0.55

1.2

1.3

1.45

1.47

g/l

0.11

132

Lesion of plantar nerve

122

0.65

0.54

1.1

1.4

—

1.55

—

Fibrosis and cirrhosis of liver

126

0.63

0.54

1.6

1.3

—

1.45

—

Diseases of pulp and periapical tissues

1101

0.89

0.54

1.2

1.3

1.22

1.46

g/l

—

Unspecified abortion

182

0.71

0.54

1.7

1.3

—

1.52

—

Benign neoplasm: Transverse colon

159

0.69

0.54

1.3

1.4

—

1.45

—

Codeine

382

1976

1.06

0.53

1.3

1.53

1.47

g/l

0.48

114

Non-follicular lymphoma, hilmo, excluding all cancers

147

0.68

0.53

1.7

1.4

—

1.48

—

Secondary hypertension

157

0.69

0.53

1.4

—

1.45

—

Temporomandibular joint disorders, including avohilmo

133

1202

1.11

0.53

1.3

1.53

1.50

g/l

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.54

0.53

1.7

1.4

—

Benign neoplasm of meninges

169

1.30

0.53

1.1

1.3

—

1.57

—

Gonarthrosis

211

1310

0.92

0.52

1.3

1.51

1.45

g/l

0.37

Cyst of kidney

0.62

0.52

1.3

—

1.44

—

Benign neoplasms

376

1978

1.06

0.52

1.3

1.2

1.50

1.47

g/l

0.17

112

Non-rheumatic valve diseases

787

0.89

0.52

1.3

1.54

1.49

g/l

—

Vasomotor and allergic rhinitis

132

1179

1.10

0.52

1.1

1.2

1.50

1.53

g/l

0.10

Hypoglycaemia, other or unspecified

136

0.66

0.51

1.0

1.3

—

1.35

—

Disorders of vestibular function (Vertigo)

984

0.89

0.51

1.3

1.38

1.48

g/l

—

Cerebrovascular diseases

158

1237

0.91

0.51

1.2

1.3

1.25

1.50

g/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

270

0.78

0.51

1.1

1.3

—

1.58

—

Covid-19 suspected case

596

0.85

0.50

1.3

1.32

1.47

g/l

—

Demyelinating diseases of the central nervous system

247

0.77

0.50

1.3

—

1.57

—

Oral corticosteroids

347

2227

0.94

0.50

1.3

1.41

1.48

g/l

0.51

117

Diseases of the eye and adnexa

362

1709

1.06

0.49

1.3

1.2

1.47

1.45

g/l

0.06

Endometriosis ASRM stages 1,2

482

1.16

0.49

1.2

1.3

1.15

1.54

g/l

—

Examination and observation for other reasons

240

1358

1.07

0.49

1.2

1.3

1.45

1.46

g/l

0.08

Chronic lower respiratory diseases

405

2313

0.95

0.49

1.2

1.3

1.43

1.47

g/l

0.32

121

Normotensive glaucoma

1.43

0.49

1.6

1.4

—

1.50

—

Bacterial pneumonia (organism specified)

890

0.89

0.49

1.2

1.3

1.44

1.45

g/l

—

Cardiodefibrillation

556

1.15

0.49

1.2

1.4

1.45

1.50

g/l

—

Myocardial infarction, strict

107

701

1.11

0.49

1.4

1.3

1.53

1.49

g/l

0.15

Visual field defects

144

0.69

0.49

1.4

1.3

—

1.40

—

Reimbursement for rheumatic diseases

140

1528

0.91

0.48

1.2

1.3

1.54

1.47

g/l

0.30

Other dorsopathies, not elsewhere classified

353

1973

0.94

0.48

1.3

1.48

g/l

0.03

Other bursopathies

312

0.80

0.48

1.2

1.3

1.56

1.50

g/l

—

Constipation

223

1715

0.93

0.48

1.4

1.3

1.47

1.49

g/l

0.08

108

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Apolipoprotein A-I [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS